Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00078221
Status:
UNKNOWN
Last Update Posted:
2008-05-09
First Post:
2004-02-20
Brief Title:
Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration AMD
Sponsor:
OccuLogix
Organization:
OccuLogix
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2005-12
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
AMD is a progressive disease of the retina which is nourished by a network of tiny blood vessels There is evidence to suggest that the flow of nutrients to the retina is impaired in patients with AMD Rheopheresis blood filtration uses blood filters that deplete excesses of large proteins fats and other substances from the blood improving blood flow to the macula potentially improving vision
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None